Status:

UNKNOWN

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Lead Sponsor:

Soonchunhyang University Hospital

Conditions:

Elderly

S-1

Eligibility:

All Genders

65-80 years

Phase:

PHASE2

Brief Summary

Stomach cancer is the most common malignant disease and the second most common cause of cancer-related deaths in the Korea. The elderly are primarily affected by the disease with most gastric cancer-r...

Detailed Description

Treatment scheme * S-1 60mg/m2/day (D1-14) Oxaliplatin: 85mg/m2 + 5DW 250mL MIV over 2-hours Each cycle is repeated every 3 weeks Response evaluation will be performed every 2 cycles Repeated cycl...

Eligibility Criteria

Inclusion

  • Age : more than 70 to 80 and ECOG PS 0-2
  • Age : more than 65 to less than 70 and ECOG PS 2
  • Histological or pathologically confirmed adenocarinoma
  • Relapsed or metastatic adenocarcinoma of stomach
  • No previous chemotherapy except adjuvant chemotherapy completed at least 12 months before enrollment
  • At least more than one measurable lesion on RECIST criteria
  • No radiation history for the target lesion
  • An estimated life expectancy of more than 3 months
  • Ability for adequate oral intake
  • Adequate BM function: defined as WBC≥4000/μL, ANC ≥1500/μL, PLT≥100,000/μL.
  • Adequate renal function: defined as Creatinine \<1.5mg/dL.
  • Adequate hepatic function: defined as total bilirubin \< 2.0mg/dL, SGOT/SGPT \< normal x 3.
  • Written informed consent

Exclusion

  • Symptomatic brain metastasis or meningeal metastasis.
  • Double primary cancer
  • Medical history of other cancer within 5 years
  • G-I bleeding or intestinal obstruction (other condition that can't have the oral intake)
  • Hypersensitivity to the 5-FU or oxaliplatin
  • Active infectious disease that need to treat systemically
  • Serious medical or psychologic condition: newly developed AMI ( within 6Ms)…

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2012

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00961077

Start Date

August 1 2009

End Date

August 1 2012

Last Update

August 18 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.